|
|
 |
|
Total Number of Holdings (excluding cash): 49
| Penumbra, Inc. |
PEN |
70975L107 |
221 |
$59,130.76 |
2.94% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
6,185 |
$54,734.70 |
2.72% |
| Masimo Corporation |
MASI |
574795100 |
319 |
$52,172.45 |
2.59% |
| Boston Scientific Corporation |
BSX |
101137107 |
515 |
$51,170.40 |
2.54% |
| Abbott Laboratories |
ABT |
002824100 |
386 |
$50,496.52 |
2.51% |
| Insulet Corporation |
PODD |
45784P101 |
193 |
$49,938.75 |
2.48% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
433 |
$48,608.58 |
2.42% |
| BioMerieux |
BIM.FP |
F1149Y232 |
376 |
$47,365.54 |
2.35% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
658 |
$46,658.78 |
2.32% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
635 |
$46,069.25 |
2.29% |
| Stryker Corporation |
SYK |
863667101 |
126 |
$45,927.00 |
2.28% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$45,741.12 |
2.27% |
| Waters Corporation |
WAT |
941848103 |
125 |
$45,270.00 |
2.25% |
| Alcon Inc. |
ALC.SW |
H01301128 |
464 |
$44,376.36 |
2.20% |
| Medtronic Plc |
MDT |
G5960L103 |
502 |
$43,990.26 |
2.19% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
2,334 |
$44,093.02 |
2.19% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
617 |
$43,896.61 |
2.18% |
| DexCom, Inc. |
DXCM |
252131107 |
648 |
$43,895.52 |
2.18% |
| Steris Plc |
STE |
G8473T100 |
197 |
$43,931.00 |
2.18% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
218 |
$43,768.98 |
2.17% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,156 |
$43,733.18 |
2.17% |
| Becton, Dickinson and Company |
BDX |
075887109 |
189 |
$42,997.50 |
2.14% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
777 |
$42,666.05 |
2.12% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,260 |
$42,182.78 |
2.10% |
| Baxter International Inc. |
BAX |
071813109 |
1,227 |
$41,411.25 |
2.06% |
| ResMed Inc. |
RMD |
761152107 |
187 |
$41,128.78 |
2.04% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,157 |
$40,375.13 |
2.01% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
493 |
$39,444.93 |
1.96% |
| Revvity, Inc. |
RVTY |
714046109 |
369 |
$38,973.78 |
1.94% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,977 |
$37,898.18 |
1.88% |
| Cochlear Limited |
COH.AU |
Q25953102 |
227 |
$37,731.13 |
1.87% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
75 |
$37,512.00 |
1.86% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
347 |
$36,799.48 |
1.83% |
| Agilent Technologies, Inc. |
A |
00846U101 |
312 |
$36,407.28 |
1.81% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$36,489.79 |
1.81% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
294 |
$36,348.91 |
1.81% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
121 |
$36,057.44 |
1.79% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,395 |
$35,705.47 |
1.77% |
| The Cooper Companies, Inc. |
COO |
216648501 |
420 |
$35,183.40 |
1.75% |
| Hologic, Inc. |
HOLX |
436440101 |
562 |
$34,461.84 |
1.71% |
| Danaher Corporation |
DHR |
235851102 |
166 |
$34,171.10 |
1.70% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$33,877.45 |
1.68% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$33,774.40 |
1.68% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
133 |
$32,319.00 |
1.61% |
| Align Technology, Inc. |
ALGN |
016255101 |
202 |
$32,160.42 |
1.60% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
1,495 |
$31,095.12 |
1.54% |
| Olympus Corporation |
7733.JP |
J61240107 |
2,340 |
$31,064.51 |
1.54% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
632 |
$27,593.12 |
1.37% |
| Teleflex Incorporated |
TFX |
879369106 |
190 |
$26,182.00 |
1.30% |
| US Dollar |
$USD |
|
5,373 |
$5,372.68 |
0.27% |
| Australian Dollar |
$AUD |
|
459 |
$288.52 |
0.01% |
| Euro |
$EUR |
|
98 |
$105.80 |
0.01% |
| Pound Sterling |
$GBP |
|
0 |
$0.14 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|